CPT code 31611 represents the surgical creation of a tracheoesophageal fistula with placement of a speech prosthesis, a procedure that restores voice function for patients who have lost laryngeal speech. Nationally, this code is important because it captures a specialized reconstructive procedure performed by otolaryngology and head and neck surgery teams, with implications for surgical service utilization, post-acute care needs, and durable medical equipment for voice rehabilitation.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent and typical care setting for the procedure, an overview of commonly applied modifiers, and context on billing practice considerations. The publication outlines benchmarks for utilization and reimbursement patterns where available, highlights relevant coding and policy updates affecting coverage and documentation, and summarizes clinical considerations tied to care pathways and post-procedure rehabilitation. Data not provided in the input (such as specific ICD-10 pairings, payer-specific coverage rules, and utilization rates) is noted as unavailable. This summary delivers the clinical and billing context needed by revenue cycle professionals, clinicians, and policy analysts working with procedures to restore speech after laryngectomy.